Template:Urethritis: Difference between revisions

Jump to navigation Jump to search
(Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''U...")
 
No edit summary
 
(14 intermediate revisions by 10 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Urinary tract infections|Urinary Tract Infections Main Page]]
|-
!
|- bgcolor="LightGrey"
!
[[Sexually transmitted diseases|Sexually Transmitted Diseases Main Page]]
!
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
Line 16: Line 25:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis (patient information)|Patient Info]]
[[Urethritis (patient information)|Patient Information]]
|-
|-  
|-  
!
!
Line 29: Line 37:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis historical perspective|Historical perspective]]
[[Urethritis historical perspective|Historical Perspective]]
|-  
|-  
!
!
Line 35: Line 43:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis pathophysiology|Pathophysiology]]
[[Urethritis classification|Classification]]
|-  
|-  
!
!
Line 41: Line 49:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis epidemiology and demographics|Epidemiology & Demographics]]
[[Urethritis pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 47: Line 55:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis risk factors|Risk Factors]]
[[Urethritis causes|Causes]]
|-  
|-  
!
!
Line 53: Line 61:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis screening|Screening]]
[[Urethritis differential diagnosis|Differentiating Urethritis from other Diseases]]
|-  
|-  
!
!
Line 59: Line 67:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis natural history, complications, and prognosis|Natural history, Complications, and Prognosis]]
[[Urethritis epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 65: Line 73:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis classification|Classification]]
[[Urethritis risk factors|Risk Factors]]
|-  
|-  
!
!
Line 71: Line 79:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis causes|Causes of Urethritis]]
[[Urethritis screening|Screening]]
|-  
|-  
!
!
Line 77: Line 85:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Urethritis differential diagnosis|Differentiating Urethritis from other Diseases]]
[[Urethritis natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 89: Line 97:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Urethritis history and symptoms|History & Symptoms]]
[[Urethritis diagnostic study of choice|Diagnostic Study of Choice]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Urethritis history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 101: Line 115:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Urethritis laboratory tests|Lab Tests]]
[[Urethritis laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 113: Line 127:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Urethritis chest x ray|Chest X Ray]]
[[Urethritis x ray|X-ray]]
|-  
|-  
!
!
Line 119: Line 133:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Urethritis MRI|MRI]]
[[Urethritis echocardiography and ultrasound|Echocardiography and Ultrasound]]
|-  
|-  
!
!
Line 125: Line 139:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Urethritis CT|CT]]
[[Urethritis CT|CT Scan]]
|-  
|-  
!
!
Line 131: Line 145:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Urethritis echocardiography or ultrasound|Echocardiography or Ultrasound]]
[[Urethritis MRI|MRI]]
|-  
|-  
!
!
Line 155: Line 169:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Urethritis dietary management|Dietary Management]]
[[Urethritis medical therapy|Medical Therapy]]
|-  
|-  
!
!
Line 161: Line 175:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Urethritis medical therapy|Medical Therapy]]
[[Urethritis interventions|Interventions]]
|-  
|-  
!
!
Line 175: Line 189:
[[Urethritis primary prevention|Primary Prevention]]
[[Urethritis primary prevention|Primary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
Line 181: Line 195:
[[Urethritis secondary prevention|Secondary Prevention]]
[[Urethritis secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
Line 194: Line 208:
|-  
|-  
!  
!  
|- bgcolor="CadetBlue"
!
Case Studies
|-
!
|- bgcolor="PaleTurquoise"
!
[[Urethritis case study one|Case #1]]
|-
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "
Line 215: Line 241:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D Review articles]
[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D Review articles]
|-  
|-  
!
!
Line 221: Line 247:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla:en-US:official&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:health_continuing_education&cx=disease_for_health_professionals&sa=N&oi=coopctx&resnum=0&ct=col3&cd=2 CME Programs]
[http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla:en-US:official&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:health_continuing_education&cx=disease_for_health_professionals&sa=N&oi=coopctx&resnum=0&ct=col3&cd=2CME Programs]
|-  
|-  
!  
!  
Line 268: Line 294:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on {{PAGENAME}}]
[http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on{{PAGENAME}}]
|-  
|-  
!  
!  
Line 274: Line 300:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://www.cdc.gov/search.do?queryText={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchButton.x=33&searchButton.y=6&action=search CDC on {{PAGENAME}}]
[http://www.cdc.gov/search.do?queryText={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchButton.x=33&searchButton.y=6&action=search CDC on{{PAGENAME}}]
|-  
|-  
!  
!  
Line 280: Line 306:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}} in the news]
[http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}}in the news]
|-  
|-  
!  
!  
Line 286: Line 312:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small>
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on{{PAGENAME}}]
|-  
|-  
!  
!  

Latest revision as of 15:44, 27 August 2021